Trademark Search in Canada

EPIRIUM BIO

View On IC.GC.CA

REGISTERED

on 31 May 2023

Last Applicant/ Owned by

EPIRIUM BIO INC.

9171 Towne Centre Drive, Suite 270San Diego CA 92122

Serial Number

2049497 filed on 23^rd Jul 2020

Registration Number

TMA1182431 registered on 31^st May 2023

Registration expiry Date

23^rd Jul 2030

Correspondent Address

OSLER, HOSKIN & HARCOURT LLP

Suite 320, World Exchange Plaza100 Queen StreetOttawa,

ONTARIO

K1P1J9

EPIRIUM BIO

Trademark usage description

pharmaceuticals for use as therapy in the fields of neurodegenerative and neuromuscular diseases and mitochondrial disease; pharmaceuticals for the tr Read More

Classification Information

Class [005]
Pharmaceuticals for use as therapy in the fields of neurodegenerative and neuromuscular diseases and mitochondrial disease; pharmaceuticals for the treatment of the central nervous system namely central nervous system diseases and disorders that affect movement; steroids.

Classification kind code

Mark Details

Serial Number

2049497

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 48 on 7^th Jan 2022	Agent Changed
Submitted for opposition 22 on 22^nd Dec 2021	Search Recorded
Submitted for opposition 20 on 22^nd Dec 2021	Examiner's First Report
Submitted for opposition 223 on 22^nd Dec 2021	Total Provisional Refusal
Submitted for opposition 256 on 5^th Jul 2021	Notification of Possible Opposition Sent
Submitted for opposition 257 on 3^rd Sept 2020	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 2^th Sept 2020	Created
Submitted for opposition 31 on 2^th Sept 2020	Formalized
Submitted for opposition 228 on 23^rd Jul 2020	International Registration
Submitted for opposition 30 on 23^rd Jul 2020	Filed

EPIRIUM BIO

Classification Information

Class [005]Pharmaceuticals for use as therapy in the fields of neurodegenerative and neuromuscular diseases and mitochondrial disease; pharmaceuticals for the treatment of the central nervous system namely central nervous system diseases and disorders that affect movement; steroids.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [005]
Pharmaceuticals for use as therapy in the fields of neurodegenerative and neuromuscular diseases and mitochondrial disease; pharmaceuticals for the treatment of the central nervous system namely central nervous system diseases and disorders that affect movement; steroids.